Serum AFP, now the most widely-used biomarkers for the diagnosis and treatment of HCC35–37, is also used to predict the possibility of recurrence for AFP-positive HCC patients after hepatectomy38,39. The gene discussed is AFP; the disease is hepatocellular carcinoma.